Evonik Industries AG (ETR:EVK)

Germany flag Germany · Delayed Price · Currency is EUR
14.56
+0.01 (0.07%)
Oct 9, 2025, 4:44 PM CET
0.07%
Market Cap6.78B
Revenue (ttm)14.71B
Net Income (ttm)424.00M
Shares Out466.00M
EPS (ttm)0.92
PE Ratio15.90
Forward PE12.01
Dividend1.17 (8.04%)
Ex-Dividend DateMay 29, 2025
Volume425,989
Average Volume1,364,190
Open14.55
Previous Close14.55
Day's Range14.54 - 14.73
52-Week Range14.49 - 22.39
Beta0.89
RSI28.76
Earnings DateNov 4, 2025

About Evonik Industries AG

Evonik Industries AG produces and sells specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, and Technology & Infrastructure segments. The Specialty Additives segment offers additives for polyurethane foams; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depr... [Read more]

Sector Materials
Founded 1847
Employees 30,669
Stock Exchange Deutsche Börse Xetra
Ticker Symbol EVK
Full Company Profile

Financial Performance

Financial Statements

News

Evonik: Revised Outlook Necessitates A Q3 2025 Update

Evonik Industries remains a fundamentally strong specialty chemicals company, now trading at attractive valuations despite recent earnings downgrades and market underperformance. EVKIY faces near-term...

8 days ago - Seeking Alpha

EQS-DD: Evonik Industries AG: Dr. Claudine Mollenkopf, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 30.09.2025 / 11:39 CET/CEST The issuer is solely responsi...

9 days ago - Wallstreet:Online

Evonik Sees Persistently Weak Demand Until Year-end; Adjusts FY25 Outlook

(RTTNews) - Evonik Industries AG has adjusted the outlook for fiscal 2025. For 2025, Evonik had previously expected adjusted EBITDA to be between 2.0 billion and 2.3 billion euros, with the company mo...

14 days ago - Nasdaq

Evonik Industries: 2025 Outlook Shift & Q3 Financials Revealed

Evonik Industries AG revises its 2025 financial outlook, reflecting market challenges and shifting demand. Jetzt den vollständigen Artikel lesen

14 days ago - Wallstreet:Online

EQS-Adhoc: Evonik Industries AG: Adjustment of the outlook for the fiscal year 2025; financial figures for the third quarter of 2025

EQS-Ad-hoc: Evonik Industries AG / Key word(s): Change in Forecast/Preliminary Results Evonik Industries AG: Adjustment of the outlook for the fiscal year 2025; financial figures for the third quarter...

14 days ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Dr. Claudine Mollenkopf, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 05.08.2025 / 10:16 CET/CEST The issuer is solely responsi...

2 months ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Thomas Wessel, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 05.08.2025 / 10:09 CET/CEST The issuer is solely responsi...

2 months ago - Wallstreet:Online

EQS-PVR: Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Evonik Industries AG Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide ...

2 months ago - Wallstreet:Online

Evonik Industries reports Q2 results

2 months ago - Seeking Alpha

EQS-PVR: Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Evonik Industries AG Evonik Industries AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide ...

3 months ago - Wallstreet:Online

EQS-AFR: Evonik Industries AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Evonik Industries AG / Preliminary announcement on the disclosure of financial statements Evonik Industries AG: Preliminary announcement of the publicat...

4 months ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Christian Kullmann, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 04.06.2025 / 11:18 CET/CEST The issuer is solely responsi...

4 months ago - Wallstreet:Online

EQS-DD: Evonik Industries AG: Dr. Claudine Mollenkopf, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 03.06.2025 / 10:46 CET/CEST The issuer is solely responsi...

4 months ago - Wallstreet:Online

Evonik Industries AG (EVKIF) Q1 2025 Earnings Call Transcript

Evonik Industries AG (OTCPK:EVKIF) Q1 2025 Results Conference Call May 12, 2025 5:00 AM ETCompany ParticipantsChristian Kullmann - Chairman of the Executive...

5 months ago - Seeking Alpha

Evonik Industries reports Q1 results

5 months ago - Seeking Alpha

Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development

Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven can...

10 months ago - Benzinga

EQS-News: Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery

EQS-News: leon-nanodrugs GmbH / Key word(s): Study results Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery 05.12....

11 months ago - Wallstreet:Online